DBS-based Biomarkers of Neurodegeneration predict Cognitive Decline and Dementia Seven Years Ahead in a Large Population-Based Sample
DBS-based biomarkers of neurodegeneration provide a cost-efficient and scalable early warning signal enabling preventive measures against AD/ADRD before the onset of serious symptoms.
Authors
- Salima Douhou
- Yuri Pettinicchi (ORCID: https://orcid.org/0000-0003-0837-8449)
- Marcela C. Otero (ORCID: https://orcid.org/0000-0003-2280-4555)
- Thorsten Kneip (ORCID: https://orcid.org/0000-0001-5480-4627)
- Yacila I. Deza‐Araujo (ORCID: https://orcid.org/0000-0002-2624-077X)
- Axel Boersch-Supan
- Martina Boersch-Supan
Institutions
- Statens Serum Institut (DK)
- National Bureau of Economic Research (US)
- Universität der Bundeswehr München (DE)
- Max Planck Institute for Social Law and Social Policy (DE)
Publication Details
- Journal
- medRxiv
- Published
- 2026-01-08
- DOI
- https://doi.org/10.64898/2026.01.07.26343614
- Primary Topic
- Health, Environment, Cognitive Aging
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Horizon 2020 Framework Programme